Table 5. Factors influencing reduction of HDL in patients with invasive breast cancer treated with postoperative chemotherapy.

Factors	B value	Standard error	Wald value	P value	95% confidence interval
Constant coefficient	0.936	0.569	2.708	0.100	–
Endocrine therapy	0.017	0.528	0.001	0.975	1.017 (0.361–2.863)
Radiotherapy	0.398	0.496	0.642	0.423	1.488 (0.563–3.937)
Targeted therapy	1.005	0.598	2.825	0.093	2.732 (0.846–8.829)
Anthracycline-based chemotherapy regimen	0.101	0.752	0.018	0.893	1.106 (0.253–4.830)
>6 chemotherapy cycles	−0.089	0.741	0.015	0.904	0.915 (0.214–3.906)